Classification of orthopaedic plaster of paris as medicament under Chapter 30 determines exemption and clearance-date duty rate.

Plaster of paris IP manufactured for orthopaedic use was treated as a medicament under Heading 3005.90, not as a mere plaster under Heading 2505.00, because it conformed to Indian Pharmacopoeial standards and was shown to be for orthopaedic use rather than dental use; it also did not meet the requirements of a patent or proprietary medicine under Chapter 30. Once classified under Heading 3005.90, the claimed benefit of Notification No. 185/86 was unavailable. Duty was also held payable at the rate in force on the date of clearance, rather than the date of manufacture.

---

---

Issues: (i) Whether plaster of paris IP manufactured for orthopaedic use was classifiable under Heading 2505.00 or under Heading 3005.90 of the Central Excise Tariff Act, 1985; (ii) whether the assessee was entitled to the benefit of Notification No. 185/86; and (iii) whether duty was chargeable at the rate prevailing on the date of clearance.

Issue (i): Whether plaster of paris IP manufactured for orthopaedic use was classifiable under Heading 2505.00 or under Heading 3005.90 of the Central Excise Tariff Act, 1985.

Analysis: The product was described by the assessee itself as conforming to Indian Pharmacopoeial standards and as being usable only for orthopaedic purposes. On that basis, it was treated as a medicament and not as a mere plaster falling under Chapter 25. Chapter Note 1(b) of Chapter 25 excluded medicaments of Chapter 30, while Chapter Note 1(b) of Chapter 30 excluded only plasters specially calcined or finely ground for use in dentistry. The assessee did not show that the product was meant for dental use, and it also did not satisfy the requirements of a patent or proprietary medicine under Chapter Note 2 of Chapter 30. The product therefore fell within pharmaceutical goods under Heading 3005.90.

Conclusion: The classification under Heading 3005.90 was upheld against the assessee.

Issue (ii): Whether the assessee was entitled to the benefit of Notification No. 185/86.

Analysis: The notification was found to be inapplicable to the goods in question once the product was held classifiable under Heading 3005.90 and not under the tariff entry covered by the claimed exemption.

Conclusion: The exemption under Notification No. 185/86 was denied against the assessee.

Issue (iii): Whether duty was chargeable at the rate prevailing on the date of clearance.

Analysis: The applicable principle was that duty is levied at the rate in force on the date of removal or clearance of the goods, and not with reference to the date of manufacture where the two differ.

Conclusion: Duty was held payable at the rate in force on the date of clearance, against the assessee.

Final Conclusion: The appeal failed because the goods were classifiable as pharmaceutical goods under Heading 3005.90, the claimed exemption was unavailable, and duty was payable at the rate applicable on clearance.

Ratio Decidendi: A product manufactured as an orthopaedic pharmacopoeial preparation is classifiable as a medicament under Chapter 30, not as a Chapter 25 plaster, where it is not shown to be for dental use and does not meet the requirements of a patent or proprietary medicine; exemption and duty incidence then follow the tariff entry and the clearance date principle.

---